Successful Treatment of Myocardial Infarction in an Infant With Kawasaki Disease

Abstract

Although early treatment with intravenous immunoglobulin reduces the risk of coronary artery aneurysms, in refractory cases of Kawasaki disease, myocardial infarction can result from thrombosis of coronary artery aneurysms. Early recognition of myocardial infarction from Kawasaki disease myocarditis can reduce morbidity and mortality. This report describes successful treatment of myocardial infarction from coronary thrombosis in an infant with Kawasaki disease using intravenous tissue plasminogen activator and abciximab.

Keywords: Kawasaki disease; abciximab; coronary artery aneurysms; coronary artery thrombosis; myocardial infarction; thrombolytics.